Showing results (91-100 of 108) with videos related to

Sort By:
Pageof 11
JAMA|May 18, 2000
Intravenous ancrod for treatment of acute ischemic stroke: the STAT study: a randomized controlled trial. Stroke Treatment with Ancrod TrialD G Sherman, R P Atkinson, T Chippendale, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|December 10, 1999
Pathophysiologic correlates of thromboembolism in nonvalvular atrial fibrillation: I. Reduced flow velocity in the left atrial appendage (The Stroke Prevention in Atrial Fibrillation [SPAF-III] study)M E Goldman, L A Pearce, R G Hart, et al.
Journal of General Internal Medicine|January 20, 1999
Stroke risk in an elderly population with atrial fibrillationW M Feinberg, R A Kronmal, A B Newman, et al.
Journal of General Internal Medicine|November 23, 2000
Development of a decision aid for atrial fibrillation who are considering antithrombotic therapyM Man-Son-Hing, A Laupacis, A M O'Connor, et al.
Annals of Emergency Medicine|May 1, 1988
Emergency department screening for unsuspected carbon monoxide exposureT L Turnbull, R G Hart, G R Strange, et al.
Cerebrovascular Diseases (Basel, Switzerland)|January 12, 2000
Cardioembolic vs. noncardioembolic strokes in atrial fibrillation: frequency and effect of antithrombotic agents in the stroke prevention in atrial fibrillation studiesR G Hart, L A Pearce, V T Miller, et al.
Stroke|December 3, 1999
Markers of thrombin and platelet activity in patients with atrial fibrillation: correlation with stroke among 1531 participants in the stroke prevention in atrial fibrillation III studyW M Feinberg, L A Pearce, R G Hart, et al.
Archives of Internal Medicine|March 25, 1996
Fecal hemoglobin excretion in elderly patients with atrial fibrillation: combined aspirin and low-dose warfarin vs conventional warfarin therapyJ L Blackshear, V S Baker, A Holland, et al.
Neurology|April 23, 2003
Neuroprotective agents for clinical trials in Parkinson's disease: a systematic assessmentB M Ravina, S C Fagan, R G Hart, et al.
Stroke|June 1, 1997
Relationship between prothrombin activation fragment F1.2 and international normalized ratio in patients with atrial fibrillation. Stroke Prevention in Atrial Fibrillation InvestigatorsW M Feinberg, E S Cornell, S D Nightingale, et al.
Pageof 11